Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

DYRK2

RBC: DYRK2 · Substrate: DYRKtide · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Abemaciclib97.10.56
Selpercatinib75.90.64
Defactinib74.80.45
Afatinib62.60.71
Osimertinib62.10.73
Palbociclib53.20.67
Dacomitinib52.10.66
Ponatinib51.50.53
Pacritinib46.00.45
Sunitinib37.20.52
Avapritinib36.80.64
Crizotinib35.90.58
Midostaurin35.60.50
Brigatinib34.40.51
Erlotinib29.60.69

Known variants

No variants catalogued.
Open in new tab